Report - HEPA-IC · 2Xeptagen, Pozzuoli (Na), Italy 3Istituto Oncologico Veneto (IOV), Padova, Italy About 3–4% of cirrhotic patients develop primary liver cancer every year. Specific serologic

Please pass captcha verification before submit form